Edmonton biotech startup hopes to use psychedelics to treat mental illness
Dr. Peter Silverstone explains how psychedelics can be used for mental health purposes and Zylorion’s business plan.
< back
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.